AJKD Author Interview – CHIP with Dr. Caitlyn Vlasschaert
Clonal hematopoiesis of indeterminate potential (CHIP), defined by the age-related ontogenesis of expanded leukemogenic variants indicative of a genetically distinct clonal [...]
albuminuria
How Does Aldosterone Activation Contribute to CKD?
Christopher Naranjo @NaranjoNephro Dr. Christopher Naranjo is a Nephrology Fellow at the University of Miami. He is passionate about hypertension, glomerular diseases, and [...]
Highlights from the September 2021 Issue
Editor’s Note: We asked authors of Original Investigations to provide short plain-language summaries that would briefly summarize what inspired their study, the basic [...]
Will You Take the Blue or Red Pill?
Calcium channel blockers (CCBs) and renin-angiotensin-system inhibitors (RASi) are two classes of antihypertensive medications frequently used as initial therapy for [...]
Coffee Consumption and Kidney Function
Data from epidemiological studies suggest coffee consumption may be associated with kidney (and other) outcomes, specifically a higher eGFR or less CKD. This is speculated to [...]
Gestational Diabetes Mellitus: A Race Effect on the Kidneys
Gestational diabetes mellitus (GDM) is defined as the onset of impaired glucose tolerance during pregnancy. Its prevalence has been steadily climbing, fueled in large part by [...]
#KidneyWk 2015: Albuminuria as a Treatment Target in CKD: Reviewing the Current Guidelines in CKD
This lecture was given by Dr. Kunihiro Matsushita, a clinical epidemiologist affiliated with Johns Hopkins Bloomberg School of Public Health, Welch Center for Prevention, [...]
Arsenic and CKD: Is There a Link?
While long-term arsenic exposure is a global health problem, is arsenic related to worsening of kidney disease or proteinuria? How does arsenic cause chronic kidney damage? A [...]